BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27786571)

  • 41. Early application of related SCT might improve clinical outcome in adult T-cell leukemia/lymphoma.
    Fuji S; Fujiwara H; Nakano N; Wake A; Inoue Y; Fukuda T; Hidaka M; Moriuchi Y; Miyamoto T; Uike N; Taguchi J; Eto T; Tomoyose T; Kondo T; Yamanoha A; Ichinohe T; Atsuta Y; Utsunomiya A;
    Bone Marrow Transplant; 2016 Feb; 51(2):205-11. PubMed ID: 26524263
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transient proliferation of donor-derived ATL cell-like lymphocytes early after allogeneic stem cell transplantation in an adult T-cell leukemia/lymphoma patient.
    Taguchi M; Imaizumi Y; Taguchi J; Imanishi D; Sasaki D; Hasegawa H; Tsushima H; Hata T; Miyazaki Y
    Blood; 2013 May; 121(21):4428-30. PubMed ID: 23704050
    [No Abstract]   [Full Text] [Related]  

  • 43. Survivin(g) adult T-cell leukemia/lymphoma.
    Janik JE; Morris JC
    Oncology (Williston Park); 2009 Dec; 23(14):1256, 1261, 1266. PubMed ID: 20120838
    [No Abstract]   [Full Text] [Related]  

  • 44. Role of hematopoietic stem cell transplantation in the treatment of non-Hodgkin's lymphoma.
    Bierman PJ; Phillips GL
    Cancer Treat Res; 2009; 144():357-97. PubMed ID: 19779882
    [No Abstract]   [Full Text] [Related]  

  • 45. Pretransplant mogamulizumab against ATLL might increase the risk of acute GVHD and non-relapse mortality.
    Inoue Y; Fuji S; Tanosaki R; Fukuda T
    Bone Marrow Transplant; 2016 May; 51(5):725-7. PubMed ID: 26691420
    [No Abstract]   [Full Text] [Related]  

  • 46. Successful treatment of HTLV-1-associated acute adult T-cell leukemia lymphoma by allogeneic bone marrow transplantation: a 12 year follow-up.
    Tholouli E; Liu Yin JA
    Leuk Lymphoma; 2006 Aug; 47(8):1691-2. PubMed ID: 16966289
    [No Abstract]   [Full Text] [Related]  

  • 47. Allogeneic bone marrow transplantation from unrelated human T-cell leukemia virus-I-negative donors for adult T-cell leukemia/lymphoma: retrospective analysis of data from the Japan Marrow Donor Program.
    Kato K; Kanda Y; Eto T; Muta T; Gondo H; Taniguchi S; Shibuya T; Utsunomiya A; Kawase T; Kato S; Morishima Y; Kodera Y; Harada M;
    Biol Blood Marrow Transplant; 2007 Jan; 13(1):90-9. PubMed ID: 17222757
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning for adult T cell leukemia/lymphoma: impact of antithymocyte globulin on clinical outcome.
    Tanosaki R; Uike N; Utsunomiya A; Saburi Y; Masuda M; Tomonaga M; Eto T; Hidaka M; Harada M; Choi I; Yamanaka T; Kannagi M; Matsuoka M; Okamura J
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):702-8. PubMed ID: 18489996
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [ATL progress 2013].
    Ishitsuka K
    Rinsho Ketsueki; 2013 Oct; 54(10):1817-27. PubMed ID: 24064832
    [No Abstract]   [Full Text] [Related]  

  • 50. Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma.
    Ishitsuka K; Tamura K
    Lancet Oncol; 2014 Oct; 15(11):e517-26. PubMed ID: 25281470
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Successful treatment of T-cell prolymphocytic leukemia with full-intensity conditioning followed by matched unrelated donor allogeneic stem cell transplantation.
    Kruspe RC; Ashraf KK; Foran JM; Salzman DE; Reddy VV; Vaughan WP
    Clin Adv Hematol Oncol; 2007 Nov; 5(11):882-4; discussion 884. PubMed ID: 18185486
    [No Abstract]   [Full Text] [Related]  

  • 52. Clinical Features and Treatment Outcomes of 81 Patients with Aggressive Type Adult T-cell Leukemia-lymphoma at a Single Institution over a 7-year Period (2006-2012).
    Kawano N; Yoshida S; Kuriyama T; Tahara Y; Yamashita K; Nagahiro Y; Kawano J; Koketsu H; Toyofuku A; Manabe T; Beppu K; Ono N; Himeji D; Yokota-Ikeda N; Inoue S; Ochiai H; Sonoda KH; Shimoda K; Ishikawa F; Ueda A
    Intern Med; 2015; 54(12):1489-98. PubMed ID: 26073237
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia.
    Shigematsu A; Kondo T; Yamamoto S; Sugita J; Onozawa M; Kahata K; Endo T; Shiratori S; Ota S; Obara M; Wakasa K; Takahata M; Takeda Y; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
    Biol Blood Marrow Transplant; 2008 May; 14(5):568-75. PubMed ID: 18410899
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adult T-cell leukemia/lymphoma in the Caribbean cohort is a distinct clinical entity with dismal response to conventional chemotherapy.
    Zell M; Assal A; Derman O; Kornblum N; Battini R; Wang Y; Narasimhulu DM; Mantzaris I; Shastri A; Verma A; Ye H; Braunschweig I; Janakiram M
    Oncotarget; 2016 Aug; 7(32):51981-51990. PubMed ID: 27341021
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bone marrow transplantation from unrelated donors for patients with adult T-cell leukaemia/lymphoma.
    Nakase K; Hara M; Kozuka T; Tanimoto K; Nawa Y
    Bone Marrow Transplant; 2006 Jan; 37(1):41-4. PubMed ID: 16247419
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of graft-versus-host disease on allogeneic hematopoietic cell transplantation for adult T cell leukemia-lymphoma focusing on preconditioning regimens: nationwide retrospective study.
    Ishida T; Hishizawa M; Kato K; Tanosaki R; Fukuda T; Takatsuka Y; Eto T; Miyazaki Y; Hidaka M; Uike N; Miyamoto T; Tsudo M; Sakamaki H; Morishima Y; Suzuki R; Utsunomiya A
    Biol Blood Marrow Transplant; 2013 Dec; 19(12):1731-9. PubMed ID: 24090597
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
    Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
    Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The current status of therapy for adult T-cell leukaemia-lymphoma in Japan.
    Yamada Y; Tomonaga M
    Leuk Lymphoma; 2003 Apr; 44(4):611-8. PubMed ID: 12769337
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Allogeneic stem cell transplantation with BEAM and alemtuzumab conditioning immediately after remission induction has curative potential in advanced T-cell non-Hodgkin's lymphoma.
    Czajczynska A; Günther A; Repp R; Humpe A; Schub N; Raff T; Nickelsen M; Schrauder A; Schrappe M; Kneba M; Gramatzki M
    Biol Blood Marrow Transplant; 2013 Nov; 19(11):1632-7. PubMed ID: 23850653
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Current management of adult T-cell leukemia/lymphoma.
    Tobinai K
    Oncology (Williston Park); 2009 Dec; 23(14):1250-6. PubMed ID: 20120837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.